Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-04Clinical Trial Update: Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy [Phase 2]
A Phase 2 trial of toripalimab for limited-stage small cell lung cancer after chemoradiotherapy has been terminated.
-
CLINICAL_TRIALS withdrawal · 2024-11-25Clinical Trial Update: Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
A Travera Inc clinical trial (NCT04985357) evaluating mass response as a biomarker for tumor sensitivity to drugs has been withdrawn; no res…
-
CLINICAL_TRIALS withdrawal · 2024-09-27Clinical Trial Update: An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer [Phase 1]
An investigational PET/CT imaging tracer, 124I-hJAA-F11, being evaluated for diagnosing lung cancer in a Phase 1 trial has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: TAS-116 Plus Palbociclib in Breast and Rb-null Cancer [Phase 1]
A Phase 1 trial investigating TAS-116 in combination with palbociclib for advanced breast cancer and RB-deficient solid tumors has been with…
-
CLINICAL_TRIALS withdrawal · 2024-06-05Clinical Trial Update: Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating lurbinectedin with durvalumab in pre-treated patients with extensive-stage small-cell lung cancer has been withdr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2020-10-30Clinical Trial Update: Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2) [Phase 1, Phase 2]
Phase 1/2 trial evaluating 177Lu-OPS201 with 68Ga-OPS202 imaging in somatostatin receptor 2–expressing cancers; study terminated with posted…
-
CLINICAL_TRIALS withdrawal · 2018-12-26Clinical Trial Update: Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating safety of rovalpituzumab tesirine for third-line and later relapsed/refractory small cell lung cancer has been with…
-
CLINICAL_TRIALS withdrawal · 2018-07-03Clinical Trial Update: Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body [NA]
A Wake Forest University Health Sciences-sponsored clinical trial evaluating cryotherapy for metastatic lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-05-25Clinical Trial Update: Molecular Signatures of Relapse in Tissue Samples From Patients With Small Cell Lung Cancer Who Are Receiving Cisplatin and Etoposide
This clinical trial update notes the withdrawal of a study investigating molecular signatures of relapse in tissue from patients with small …
-
CLINICAL_TRIALS withdrawal · 2018-04-17Clinical Trial Update: Pulmonary Interstitial Lymphography in Early Stage Lung Cancer [NA]
The Stanford University-sponsored trial 'Pulmonary Interstitial Lymphography in Early Stage Lung Cancer' has been terminated. The trial stat…
-
CLINICAL_TRIALS withdrawal · 2017-08-10Clinical Trial Update: NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer [Phase 2]
The Phase 2 trial of NovoTTF-100A Therapy for refractory CNS-involved small cell lung cancer (including brain metastases) has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2017-04-24Clinical Trial Update: Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
A Phase 1 clinical trial of talazoparib in patients with advanced or metastatic solid tumors unsuitable for surgery and with liver or kidney…
-
CLINICAL_TRIALS withdrawal · 2017-02-07Clinical Trial Update: MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases [Phase 2]
Phase 2 trial of MRI-guided High Intensity Focused Ultrasound (HIFU) with ThermoDox for palliation of painful bone metastases has been withd…
-
CLINICAL_TRIALS withdrawal · 2016-12-07Clinical Trial Update: A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients [Phase 1, Phase 2]
This Phase 1/Phase 2 trial evaluating CDX-1401 in combination with Poly-ICLC and pembrolizumab for previously treated advanced solid tumors …
-
CLINICAL_TRIALS withdrawal · 2016-07-20Clinical Trial Update: Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating liposomal SN-38 for small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-07-06Clinical Trial Update: A Study to Evaluate the Good and Bad Effects of BIBF1120 in Small Cell Lung Cancer Patients Who Have Previously Benefited From First-line Platinum-based Chemotherapy [Phase 2]
Phase 2 trial evaluating BIBF1120 (nintedanib) in platinum-sensitive small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-11-13Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery [Phase 1]
Phase 1 trial of peripheral stem cell transplantation for metastatic or unresectable cancers including breast cancer, renal cell carcinoma, …
-
CLINICAL_TRIALS withdrawal · 2015-10-07Clinical Trial Update: Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial of metronomic docetaxel and bevacizumab in small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-05-19Clinical Trial Update: Radiation Therapy in Preventing Brain Metastases in Patients With Small Cell Lung Cancer [Phase 3]
The Phase 3 trial evaluating radiation therapy to prevent brain metastases in small cell lung cancer has been withdrawn, sponsored by Virgin…
-
CLINICAL_TRIALS withdrawal · 2014-12-31Clinical Trial Update: Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating first-line panobinostat with etoposide and cisplatin for extensive-stage small cell lung cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-08-27Clinical Trial Update: Hypoxia-guided Radiotherapy With Cisplatin-etoposide in Stage I-III : Small Cell Lung Cancer(SCLC) [NA]
The trial investigating hypoxia-guided radiotherapy with cisplatin and etoposide for stage I-III small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-05-08Clinical Trial Update: A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC) [Phase 2]
A Phase 2 randomized study evaluating two enoxaparin sodium doses in combination with standard chemotherapy for stage small cell lung cancer…
-
CLINICAL_TRIALS withdrawal · 2012-02-09Clinical Trial Update: INNO-206 in Patients With Small Cell Lung Cancer (SCLC) [Phase 2]
CytRx has withdrawn its Phase 2 clinical trial of INNO-206 for small cell lung cancer.
-
CLINICAL_TRIALS withdrawal · 2007-04-05Clinical Trial Update: Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer [Phase 2]
A Phase 2 trial of oxaliplatin plus CPT-11 (irinotecan) for extensive-stage small cell lung cancer has been terminated.